Exelixis Reveals Preliminary Financial Outcomes for 2024 and Sets Ambitious Goals for 2025
January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
MORE NEWS
May 26, 2026 - 04:06
How Investors Are Reacting To Brink's (BCO) Record Free Cash Flow And Margin ExpansionEarlier this month, Brink`s reported a strong first quarter, with revenue rising 10.3% year on year and higher-margin AMS, DRS, and global services driving EBITDA margin expansion and record free...
May 25, 2026 - 18:00
Financial Exchanges & Data Stocks Q1 Teardown: Tradeweb Markets (NASDAQ:TW) Vs The RestThe close of earnings season offers a clear moment to look back and separate the winners from the laggards. For the financial exchanges and data sector, the first quarter of the year presented a...
May 25, 2026 - 11:24
Renter warning as Budget tax changes expected to fuel rise of corporate landlords: 'Quite surprised'Real estate professionals say they are `quite surprised` by how much the upcoming Budget appears to favor corporate landlords over individual investors. The expected tax changes are likely to...
May 24, 2026 - 21:19
A Look At Regions Financial (RF) Valuation After Recent Steady Share Price PerformanceRegions Financial (RF) has been catching the eye of investors lately, as its stock price holds steady after a series of mixed short-term moves. The shares recently closed at US$27.83, showing a...